No takes yet. Share an insight, caveat, or question.
Secondary analysis reveals differences in health-related quality of life concerning treatment side effects in renal cell carcinoma, suggesting stage-specific patient-reported outcomes are essential.
Shah et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: